Table 3.
Study | n | Successful ERCP | Days to resolution | Complication rate | Further intervention |
---|---|---|---|---|---|
Present study | 29 | n = 27 | 4 | n = 2/29 | n = 0 |
Donnellan et al.24 | 48 | n = 44 | 5 | n = 0 | n = 0 |
Tzovaras et al.26 | 20 | n = 19 | NA | n = 1 | n = 1 |
Familiari et al.35 | 85 | 96.3% | NA | 2.9% | 2.3% |
Mavrogiannis et al.31 | 52 | 100% | 2–4 | 7.7% | 0% |
Katsinelos et al.14 | 60 | 94% | NA | 13% | 1.6% |
NA, not available